Literature DB >> 9466991

Tissue-specific in vivo transcription start sites of the human and murine cystic fibrosis genes.

N L White1, C F Higgins, A E Trezise.   

Abstract

The in vivo transcription start sites of the human cystic fibrosis transmembrane conductance regulator gene ( CFTR ) and its murine homologue ( Cftr ) have been mapped in a range of tissues using the technique of 5' rapid amplification of cDNA ends (5' RACE). These are the first in vivo transcription start sites for CFTR or Cftr to be reported. Distinct, tissue-specific patterns of CFTR start site usage were identified in both mouse and human. In particular, striking variation in the position of the murine Cftr transcription start site was seen along the length of the intestinal tract; different start sites being utilized in ileum and in duodenum. In humans, distinct transcription start sites are utilized in adult and foetal lungs. In addition, a novel 5'-untranslated exon of murine Cftr , denoted exon -1, was identified and shown to be expressed exclusively in mouse testis. Expression of exon -1-containing Cftr transcripts was shown by mRNA in situ hybridization to be confined to the germ cells and to be regulated during spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466991     DOI: 10.1093/hmg/7.3.363

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  15 in total

1.  Genomic sequence analysis of Fugu rubripes CFTR and flanking genes in a 60 kb region conserving synteny with 800 kb of human chromosome 7.

Authors:  H Davidson; M S Taylor; A Doherty; A C Boyd; D J Porteous
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

2.  TIPR: transcription initiation pattern recognition on a genome scale.

Authors:  Taj Morton; Weng-Keen Wong; Molly Megraw
Journal:  Bioinformatics       Date:  2015-08-08       Impact factor: 6.937

3.  Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis.

Authors:  Laia Masvidal; Susana Igreja; Maria D Ramos; Antoni Alvarez; Javier de Gracia; Anabela Ramalho; Margarida D Amaral; Sara Larriba; Teresa Casals
Journal:  Eur J Hum Genet       Date:  2013-10-16       Impact factor: 4.246

4.  Functional analysis of a promoter variant identified in the CFTR gene in cis of a frameshift mutation.

Authors:  Victoria Viart; Marie Des Georges; Mireille Claustres; Magali Taulan
Journal:  Eur J Hum Genet       Date:  2011-08-17       Impact factor: 4.246

Review 5.  Decoding sORF translation - from small proteins to gene regulation.

Authors:  Luis Enrique Cabrera-Quio; Sarah Herberg; Andrea Pauli
Journal:  RNA Biol       Date:  2016-08-12       Impact factor: 4.652

6.  In vivo analysis of DNase I hypersensitive sites in the human CFTR gene.

Authors:  D S Moulin; A L Manson; H N Nuthall; D J Smith; C Huxley; A Harris
Journal:  Mol Med       Date:  1999-04       Impact factor: 6.354

7.  DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis.

Authors:  N Kälin; A Claass; M Sommer; E Puchelle; B Tümmler
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

8.  Alternative splicing of the ovine CFTR gene.

Authors:  Fiona C Broackes-Carter; Sarah H Williams; Pei Ling Wong; Nathalie Mouchel; Ann Harris
Journal:  Mamm Genome       Date:  2003-11       Impact factor: 2.957

9.  Multiple mechanisms influence regulation of the cystic fibrosis transmembrane conductance regulator gene promoter.

Authors:  Marzena A Lewandowska; Fabricio F Costa; Jared M Bischof; Sarah H Williams; Marcelo B Soares; Ann Harris
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-23       Impact factor: 6.914

10.  Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice.

Authors:  Maziar Divangahi; Haouaria Balghi; Gawiyou Danialou; Alain S Comtois; Alexandre Demoule; Sheila Ernest; Christina Haston; Renaud Robert; John W Hanrahan; Danuta Radzioch; Basil J Petrof
Journal:  PLoS Genet       Date:  2009-07-31       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.